Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NZ Plans Major Regulatory Overhaul, New Independent Agency

Executive Summary

The New Zealand health ministry has launched a consultation on a wide-ranging overhaul of the therapeutic product regulatory system. The new scheme, which will take a few years to put into place, will fill a number of regulatory gaps, set up a new independent drugs and devices agency,  and generally bring New Zealand into line with other regulatory systems around the world.

You may also be interested in...



Australia, NZ Again Drop Plan For Joint Therapeutic Product Regulator

Australia and New Zealand once again ditch plans for a joint drug, nutritional product and medical device regulator, wiping away all made in three years to harmonize the two countries' regulatory frameworks.

Post-Brexit UK Risks Being ‘Left Out In The Cold’ As EU Coordinates Action On Shortages

The UK is not alone in experiencing drug shortages, as data from across Europe show, but its departure from the EU makes it more difficult to respond to supply chain pressures, according to new research.

EU Countries Offered Funding To Contribute to African Regulatory Strengthening

Training projects are intended to strengthen the African regulatory environment, boost the capacity of the African Medicines Agency, facilitate regulatory reliance, and increase joint new drug assessments.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS124481

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel